[Therapy with 25-hydroxycholecalcipherol (25-HCC) in calcium resorption errors during anti-epileptic treatment].
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D002128:Calcium Metabolism Disorders / Q000139:chemically induced / Q000188:drug therapy*; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism; D014807:Vitamin D / Q000627:therapeutic use
D000927:Anticonvulsants; D006887:Hydroxycholecalciferols; D014807:Vitamin D; D002118:Calcium
Therapie der Kalziumresorptionsstörung unter antiepileptischer Behandlung mit 25-Hydroxycholekalziferol (25-HCC)